Atlantic Biologicals
Atlantic Biologicals is a privately held, Miami-based pharmaceutical distributor founded in 1998 that supplies brand, generic, and critical care drugs — including its exclusive UDose™ unit-dose line — to hospitals, clinics, LTC, correctional, and home infusion facilities nationwide from five US distribution centers.
- Company typePrivate
- Founded1998
- HeadquartersMiami, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Atlantic Biologicals does
Atlantic Biologicals is a privately held pharmaceutical distributor founded in 1998 and headquartered in Miami, Florida. The company distributes brand, generic, and critical care pharmaceuticals alongside its exclusive UDose™ line of FDA-registered, cGMP-compliant unit-dose repackaged medications — covering 60+ SKUs across oral solids, liquid cups, preloaded oral syringes, single pill packs, and powder packets. Products are individually barcoded and serialized, registered with First Databank, and integrated with Epic Systems for EHR compatibility. The company operates five distribution centers in Arizona, Florida, Maryland, North Carolina, and Tennessee, enabling nationwide delivery to the US, Puerto Rico, and the Hawaiian Islands.
The company serves a diversified customer base including acute care hospitals, physicians' offices, oncology clinics, diagnostic centers, freestanding clinics, long-term care facilities, correctional facilities, surgical centers, retail pharmacies, and home infusion facilities. Its core technology stack centers on a 24/7 online web portal (app.atlanticbiologicals.com), barcode/serialization for unit-dose safety, and integration with drug databases and EHR systems. Revenue is generated through transaction-based pharmaceutical sales via direct sales engagement, with quote-based pricing, bulk purchasing options, and no publicly disclosed price list. The business is sales-led, supported by an inside sales team, field sales representatives, and a content-marketing engine (blog, weekly newsletter, social media, and industry event participation). Ownership appears founder-led or closely held with no disclosed institutional investors, parent company, or external funding.
Atlantic Biologicals firmographics
Firmographics- Name
- Atlantic Biologicals
- Legal name
- Atlantic Biologicals Corporation
- Website
- https://atlanticbiologicals.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Atlantic Biologicals is a privately held, Miami-based pharmaceutical distributor founded in 1998 that supplies brand, generic, and critical care drugs — including its exclusive UDose™ unit-dose line — to hospitals, clinics, LTC, correctional, and home infusion facilities nationwide from five US distribution centers.
- Ownership category
- akta.pro rank
Atlantic Biologicals industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industries
- Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD), Specialty Pharmacy & Biologics Distribution (CRAOAHAD), Pharmaceutical Labels & Patient Information Packaging (Labels, IFUs, Booklets) (IMALAIAK)
Keywords
Where Atlantic Biologicals is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
Atlantic Biologicals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Distribution Sales: Atlantic Biologicals generates revenue through the sale and distribution of brand, generic, and critical care pharmaceuticals, as well as UDose™ unit-dose repackaged medications, to healthcare facilities. The company sells products in bulk quantities through its online webstore and direct sales team, shipping nationwide and in Puerto Rico. Revenue is derived from product margins on pharmaceutical sales to hospitals, physicians' offices, oncology clinics, diagnostic centers, freestanding clinics, LTC facilities, correctional facilities, surgical centers, retail pharmacies, and home infusion facilities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Quote-based pharmaceutical pricing for healthcare facilities |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Atlantic Biologicals product offering
Product offeringCore offering
Atlantic Biologicals is a pharmaceutical distributor that sells brand, generic, and critical care pharmaceuticals to healthcare facilities. The company is the exclusive distributor of UDose™, a proprietary line of FDA-registered, cGMP-compliant repackaged unit-dose medications spanning 60+ SKUs in oral solids, liquids, preloaded oral syringes, liquid cups, and powders. Products are barcoded, serialized, and sourced directly from 85+ FDA manufacturers, distributed nationwide from five strategically placed distribution centers.
Product overview
Atlantic Biologicals is a pharmaceutical distributor offering a portfolio of products centered on its exclusive UDose™ brand of unit-dose repackaged medications. The product line includes oral liquid syringes, solid single pill packs, liquid cups, and powders—all featuring bar-coding and serialization for medication safety. The company distributes brand, generic, and critical care pharmaceuticals through five strategically placed distribution centers nationwide, with an online web portal for 24/7 ordering.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Eliminates in-house repackaging, reducing risk of medication errors and freeing pharmacy staff for direct patient care
- +2 more outcomes
Companies that use Atlantic Biologicals
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles4 records
Atlantic Biologicals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature3 records
Atlantic Biologicals partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Medical Packaging Inc., LLC (MPI)coreAtlantic Biologicals partners with Medical Packaging Inc., LLC (MPI) for unit dosage packaging solutions. MPI provides high-quality pharmaceutical packaging equipment, consumable materials, and proprietary Pak-EDGE™ UD Barcode Labeling Software. This partnership supports Atlantic's unit-dose repackaging operations with equipment selection, staff training, and implementation support.
- 85+ FDA ManufacturerscoreAtlantic Biologicals is a direct authorized distributor of 85+ FDA manufacturers, providing the company with brand, generic, and injectable pharmaceuticals. These manufacturer relationships form the backbone of the company's supply chain, enabling it to offer a broad portfolio of pharmaceutical products to healthcare facilities.
- Epic SystemscoreUDose™ products are uploaded with Epic Systems for seamless EHR integration, enabling Atlantic Biologicals' unit-dose medications to integrate with hospital electronic health record systems for medication administration tracking and safety.
- First DatabankcoreUDose™ products are registered with First Databank, ensuring Atlantic Biologicals' medications are properly coded and listed in drug databases used by healthcare facilities for formulary management and clinical decision support.
Scale indicators5 records
Recent moves6 records
Expansion highlights4 records
Atlantic Biologicals competitors and assessment
Company assessmentOthers
- PharmaLex: Pharmaceutical regulatory and compliance consulting provider with deep FDA, cGMP, and serialization expertise. Adjacent comparable — supports the same regulatory and quality framework Atlantic Biologicals operates under for repackaging and distribution compliance.
Emerging players
- RxBenefits: Pharmacy benefit optimizer for self-funded employer health plans, with proprietary drug distribution and contracting capabilities. Adjacent comparable — operates in pharmaceutical procurement and distribution economics for institutional buyers, similar to Atlantic Biologicals' hospital/LTC focus.
Broad incumbents
- CuraScript SD (Express Scripts): Specialty pharmaceutical distributor serving oncology, immunology, and other complex-therapy providers. Comparable as a specialty pharma distributor targeting similar high-touch institutional segments where Atlantic Biologicals positions UDose™ unit-dose solutions.
- McKesson Corporation: Largest US pharmaceutical distributor (Big-3) serving retail chains, hospitals, and health systems. Comparable as the dominant incumbent against which mid-sized specialty distributors like Atlantic Biologicals compete for hospital, oncology, and LTC accounts.
- Cencora (formerly AmerisourceBergen): Big-3 pharmaceutical wholesaler with extensive specialty distribution, oncology, and animal health segments. Comparable as a broad incumbent with overlap in hospital, specialty pharma, and biologics distribution.
- HD Smith (now part of Cencora): Was the largest privately held US pharmaceutical distributor before Cencora acquisition. Historically comparable to Atlantic Biologicals as a specialty drug wholesaler serving independent pharmacies and hospitals; now an integrated arm of a Big-3 incumbent.
- Cardinal Health: Big-3 pharmaceutical distributor with national hospital, retail pharmacy, and specialty distribution arms. Directly comparable as a large-scale incumbent competing for the same hospital and institutional customer base that Atlantic Biologicals serves.
Direct peers
- Smith Drug Company: Privately held pharmaceutical wholesaler serving independent retail pharmacies, hospitals, and long-term care facilities. Comparable to Atlantic Biologicals as a mid-sized specialty distributor with similar institutional customer focus.
- Morris & Dickson: Privately held full-line pharmaceutical distributor serving hospitals, retail pharmacies, and healthcare facilities across the southern US. Closely comparable to Atlantic Biologicals as a mid-sized regional specialty wholesaler with similar customer mix.
- Anda Inc. Teva's US pharmaceutical distribution arm distributing generic, brand, and specialty pharmaceuticals to pharmacies, hospitals, and healthcare systems. Comparable to Atlantic Biologicals as a specialty/generic distributor with national reach.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Atlantic Biologicals social profiles
Digital presenceAtlantic Biologicals financial estimates
Financial estimateRevenue estimate
Valuation estimate
Atlantic Biologicals leadership team
Management profileNumber of profiles
Profiles3 records
Atlantic Biologicals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Atlantic Biologicals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Atlantic Biologicals
What does Atlantic Biologicals do?
Atlantic Biologicals is a pharmaceutical distributor that sells brand, generic, and critical care pharmaceuticals to healthcare facilities. The company is the exclusive distributor of UDose™, a proprietary line of FDA-registered, cGMP-compliant repackaged unit-dose medications spanning 60+ SKUs in oral solids, liquids, preloaded oral syringes, liquid cups, and powders. Products are barcoded, serialized, and sourced directly from 85+ FDA manufacturers, distributed nationwide from five strategically placed distribution centers.
Is Atlantic Biologicals a public or private company?
Atlantic Biologicals is a private company. It is classified as unknown and is currently operating.
When was Atlantic Biologicals founded?
Atlantic Biologicals was founded in 1998. It employs 51 to 100 people.
Where is Atlantic Biologicals based?
Atlantic Biologicals is headquartered in Miami, United States, in the North America region.
How does Atlantic Biologicals make money?
One revenue line is on record: pharmaceutical Distribution Sales.
Who are Atlantic Biologicals's main competitors?
PharmaLex is listed as an others. RxBenefits is listed as an emerging player. Broad incumbents are CuraScript SD (Express Scripts), McKesson Corporation, Cencora (formerly AmerisourceBergen), HD Smith (now part of Cencora) and Cardinal Health. Direct peers are Smith Drug Company, Morris & Dickson and Anda Inc..
Does Atlantic Biologicals have an API?
No public API is recorded for Atlantic Biologicals.
What industry is Atlantic Biologicals in?
Atlantic Biologicals's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of TLAIACAD, Pharmaceutical & Life Sciences Warehousing (GDP-Compliant). Its NAICS code is 424210 and its SIC code is 5122.